ArticleBMC microbiology2025
Elimination of pathogenic Aeromonas and Flavobacterium strains in the aquatic environment using CaviPlasma.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe key limiting factor for recirculating aquaculture systems (RAS) is maintaining good water quality, which requires keeping the system free of bacterial pathogens. In this study, we investigated the potential of CaviPlasma water treatment technology for the industrial-scale disinfection of RAS water.
methodsWe focused on the remediation of model suspensions containing Aeromonas salmonicida, Aeromonas hydrophila, and Flavobacterium psychrophilum, which are important fish disease causative agents that represent significant health risks for reared fish. The CaviPlasma technology utilized is based on advanced oxidation processes induced by plasma discharge in fast-flowing liquids, synergized with the hydromechanical effects of cavitation.
resultsOur results demonstrated strong biocidal efficiency of CaviPlasma water treatment without chemical or medical additives. F. psychrophilum was completely eliminated immediately after treatment, even at the lowest plasma dose (8.4 kJ/L). Aeromonads displayed slightly higher resistance; instant elimination of aeromonads was achieved with a plasma dose of 25.2 kJ/L, or 33.6 kJ/L. However, during post-treatment incubation, the concentration of live aeromonads gradually decreased to zero, even at the lowest plasma dose.
conclusionsOur pilot study revealed that CaviPlasma technology is a promising sanitization method with potential for use in recirculation aquaculture systems (RAS). It offers approximately m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.